Literature DB >> 12803130

Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

László Váróczy1, Lajos Gergely, Szabolcs Szakáll, Arpád Illés.   

Abstract

Angiocentric lymphomatoid granulomatosis is a rare lymphoproliferative disease, mainly associated with pulmonary manifestation. Its origin is unknown, but Epstein-Barr virus may be one of the etiological factors. A 51-year-old male had an abdominal laparotomy in 1994 and a large granulomatous mass was removed from behind the cecum. No specific therapy was administered. In February 1998 multiple pulmonary lesions were found by X-ray and thoracoscopic biopsy was made. The histopathological diagnosis was angiocentric lymphomatoid granulomatosis. The patient received 6 cycles of CHOP chemotherapy, with which a complete remission was achieved. A consistent severe hypogammaglobulinaemia was detected, so the diagnosis of common variable immunodeficiency (CVID) was established. The diagnosed CVID was the probable causative factor of the angiocentric lymphomatoid granulomatosis. After the CHOP treatment, the patient is on intravenous immunoglobulin substitution and is well up to today.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12803130

Source DB:  PubMed          Journal:  Haematologia (Budap)        ISSN: 0017-6559


  3 in total

1.  A pediatric case of low-grade lymphomatoid granulomatosis presenting with a cerebellar mass.

Authors:  A T K Kendi; A M McKinney; H B Clark; S A Kieffer
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

Review 2.  Granulomatous disease in common variable immunodeficiency.

Authors:  Yoshikazu Morimoto; John M Routes
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

3.  A rare case of pulmonary lymphomatoid granulomatosis complicated with venous thrombosis.

Authors:  Senem Maral; Murat Albayrak; Hacer Berna Afacan Ozturk; Funda Incekara; Abdulkerim Yıldız; Pınar Comert; Aynur Albayrak; Merih Reis Aras; Sadi Kaya
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 0.670

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.